To repeal Public Law 114-145 to ensure that the Drug Enforcement Administration has the authority to carry out needed enforcement actions for drug diversion control investigations and operations to combat the opioid epidemic, and for other purposes.
Restoring Enforcement Standards to Track Opioids Responsively and Effectively Act of 2019 or the RESTORE Act of 2019
This bill repeals the Ensuring Patient Access and Effective Drug Enforcement Act of 2016. That act modified the standards that the Drug Enforcement Administration must apply when deciding whether to deny, revoke, or suspend the registration of a manufacturer, distributor, or dispenser of controlled substances (i.e., substances regulated under federal law based on their medical use and potential for dependence and abuse).
Introduced in House
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line